Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
United European Gastroenterology Week
Semaglutide improves cardiovascular outcomes in patients with risk of fibrotic MASH - a subgroup analysis from the SELECT trial
United European Gastroenterology Week
:
Download poster (.pdf)
{{ getPageNum(PDFPage) }}